Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Assets Average (2020 - 2025)

Revolution Medicines has reported Assets Average over the past 6 years, most recently at $2.3 billion for Q4 2025.

  • Quarterly results put Assets Average at $2.3 billion for Q4 2025, up 6.6% from a year ago — trailing twelve months through Dec 2025 was $2.3 billion (up 6.6% YoY), and the annual figure for FY2025 was $2.5 billion, up 6.34%.
  • Assets Average for Q4 2025 was $2.3 billion at Revolution Medicines, down from $2.3 billion in the prior quarter.
  • Over the last five years, Assets Average for RVMD hit a ceiling of $2.5 billion in Q1 2025 and a floor of $657.8 million in Q2 2022.
  • Median Assets Average over the past 5 years was $1.1 billion (2023), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Assets Average: fell 17.03% in 2022 and later soared 110.59% in 2024.
  • Revolution Medicines' Assets Average stood at $736.5 million in 2021, then grew by 11.19% to $818.9 million in 2022, then surged by 85.97% to $1.5 billion in 2023, then skyrocketed by 41.87% to $2.2 billion in 2024, then grew by 6.6% to $2.3 billion in 2025.
  • The last three reported values for Assets Average were $2.3 billion (Q4 2025), $2.3 billion (Q3 2025), and $2.4 billion (Q2 2025) per Business Quant data.